NEW YORK (GenomeWeb News) — Roche yesterday said it has extended its tender offer deadline to buy Ventana Medical Systems to the close of business on Aug. 23.
 
Roche's original deadline lapsed last night, and the federal anti-trust waiting period passed earlier this week.
  
In response, Ventana reiterated that the offer remains “wholly inadequate” and that it is “significantly below our current market price.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.